BACKGROUND: Cardiovascular-kidney-metabolic (CKM) syndrome is a recently proposed framework emphasizing the interconnected ...
New research on tirzepatide, the drug behind Zepbound and Mounjaro, suggests it could significantly lower the risk of major ...
GLP-1 weight loss drugs containing tirzepatide (Mounjaro, Zepbound) can reduce heart-related health risks for people with ...
Boston University Chobanian & Avedisian School of Medicine researchers Vanessa Xanthakis, PhD, FAHA, associate professor of ...
New data analyzing more than 20,000 patients from three major NIH studies show that elevated Lipoprotein(a) [Lp(a)] is ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Please provide your email address to receive an email when new articles are posted on . Salt substitutes reduced all-cause and cardiovascular mortality, as well as cardiovascular events, in eight ...
Cardiovascular diseases are the number one cause of death globally. They include conditions such as coronary heart disease (CHD), heart attack, high blood pressure, arrhythmias, congenital heart ...
Recent systematic reviews and topic modeling studies reveal a surge in artificial intelligence applications across cardiovascular medicine, from diagnostics to prognostics. Deep learning dominates ...
The US Food and Drug Administration (FDA) today approved a software program that can noninvasively identify coronary artery blockages, avoiding the need to diagnose the problem via cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results